Robert S Benjamin Selected Research

Liposarcoma

1/2023	Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma.
7/2009	Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert S Benjamin Research Topics

Disease

68	Neoplasms (Cancer) 02/2024 - 06/2002
55	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 09/2002
28	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 12/2003
11	Ewing Sarcoma (Sarcoma, Ewing) 07/2020 - 02/2007
11	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2002
9	Disease Progression 01/2022 - 03/2003
7	Cardiotoxicity 01/2021 - 12/2004
5	Aggressive Fibromatosis (Desmoid) 08/2012 - 01/2006
5	Necrosis 01/2009 - 07/2004
4	Melanoma (Melanoma, Malignant) 01/2017 - 04/2002
3	Hemangiosarcoma (Angiosarcoma) 01/2022 - 12/2005
3	Rhabdomyosarcoma 01/2020 - 11/2007
3	Breast Neoplasms (Breast Cancer) 05/2017 - 12/2005
3	Hemorrhage 01/2016 - 06/2002
3	Leiomyosarcoma 01/2016 - 06/2003
3	Myxoid Liposarcoma 12/2012 - 03/2008
3	Neoplasm Metastasis (Metastasis) 10/2012 - 07/2002
3	Synovial Sarcoma (Synovioma) 07/2009 - 11/2007
2	Liposarcoma 01/2023 - 07/2009
2	Desmoplastic Small Round Cell Tumor 10/2018 - 01/2018
2	Giant Cell Tumor of Bone 01/2015 - 09/2003
2	Solitary Fibrous Tumors 05/2013 - 11/2011
2	Fever (Fevers) 01/2010 - 06/2006
2	Neutropenia 01/2010 - 06/2006
2	Fibrosarcoma 07/2009 - 11/2003
2	Margins of Excision 01/2006 - 05/2003
2	Thrombocytopenia (Thrombopenia) 08/2003 - 03/2003
2	Lymphoma (Lymphomas) 03/2003 - 06/2002
1	Wounds and Injuries (Trauma) 12/2022
1	Phyllodes Tumor (Cystosarcoma Phylloides) 04/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Warts (Wart) 10/2018
1	Airway Obstruction (Choking) 05/2017
1	Asphyxia (Suffocation) 05/2017
1	Giant Cell Tumors (Giant Cell Tumor) 05/2017
1	Ependymoma 04/2015

Drug/Important Bio-Agent (IBA)

27	Imatinib Mesylate (Gleevec)FDA Link 07/2017 - 03/2003
18	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2002
11	Ifosfamide FDA LinkGeneric 04/2021 - 09/2002
6	Gemcitabine FDA Link 01/2023 - 07/2007
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2008
5	AnthracyclinesIBA 01/2020 - 12/2004
4	Docetaxel (Taxotere)FDA Link 01/2023 - 07/2007
4	pazopanib FDA Link 01/2020 - 11/2017
4	Cisplatin (Platino)FDA LinkGeneric 10/2018 - 07/2004
4	Phosphotransferases (Kinase)IBA 08/2009 - 09/2004
3	thiamine triphosphorate (TTP)IBA 07/2011 - 05/2007
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2008 - 01/2006
2	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2021 - 02/2014
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2009
2	CytokinesIBA 01/2018 - 04/2002
2	Trastuzumab (Herceptin)FDA Link 11/2017 - 12/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017 - 01/2014
2	Vincristine (Oncovin)FDA LinkGeneric 10/2017 - 01/2015
2	Denosumab FDA Link 05/2017 - 01/2015
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 01/2010
2	InterferonsIBA 01/2015 - 08/2012
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 06/2014 - 07/2011
2	Insulin-Like PeptidesIBA 12/2011 - 10/2006
2	Temozolomide (Temodar)FDA LinkGeneric 11/2011 - 12/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011 - 11/2007
2	DNA (Deoxyribonucleic Acid)IBA 10/2010 - 02/2008
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2008 - 05/2007
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2007 - 07/2005
2	Indicators and Reagents (Reagents)IBA 12/2004 - 03/2003
1	ripretinibIBA 02/2024
1	avapritinibIBA 02/2024
1	pembrolizumabIBA 01/2022
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 07/2020
1	AntibodiesIBA 07/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	RadiumIBA 01/2019
1	ST 679IBA 12/2017
1	Lapatinib (GW572016)FDA Link 11/2017
1	Vorinostat FDA Link 11/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2017
1	Everolimus FDA Link 11/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	Endothelin-3 (Endothelin 3)IBA 01/2017
1	TroponinIBA 01/2017
1	TOR Serine-Threonine KinasesIBA 12/2016
1	Somatomedin Receptors (Somatomedin Receptor)IBA 12/2016
1	Drug CombinationsIBA 12/2016

Therapy/Procedure

45	Therapeutics 01/2023 - 01/2002
31	Drug Therapy (Chemotherapy) 04/2021 - 04/2002
18	Radiotherapy 12/2022 - 05/2003
6	Neoadjuvant Therapy 01/2020 - 09/2002
4	Adjuvant Chemotherapy 05/2017 - 11/2003
3	Immunotherapy 01/2022 - 07/2012
3	Aftercare (After-Treatment) 01/2007 - 12/2004
2	Combination Drug Therapy (Combination Chemotherapy) 12/2017 - 12/2004
2	Platelet Transfusion (Blood Platelet Transfusions) 03/2003 - 06/2002
1	Investigational Therapies (Experimental Therapy) 01/2023
1	Hyperthermic Intraperitoneal Chemotherapy 10/2018
1	Cytoreduction Surgical Procedures 10/2018
1	Tracheostomy 05/2017
1	Combined Modality Therapy 01/2016